𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease

✍ Scribed by Paul Henderson; Johan E. van Limbergen; Jürgen Schwarze; David C. Wilson


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
1017 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

✦ Synopsis


The intestinal epithelium not only acts as a physical barrier to commensal bacteria and foreign antigens but is also actively involved in antigen processing and immune cell regulation. The inflammatory bowel diseases (IBDs) are characterized by inflammation at this mucosal surface with well-recognized defects in barrier and secretory function. In addition to this, defects in intraepithelial lymphocytes, chemokine receptors, and pattern recognition receptors promote an abnormal immune response, with increased differentiation of proinflammatory cells and a dysregulated relationship with professional antigen-presenting cells. This review focuses on recent developments in the structure of the epithelium, including a detailed account of the apical junctional complex in addition to the role of the enterocyte in antigen recognition, uptake, processing, and presentation. Recently described cytokines such as interleukin-22 and interleukin-31 are highlighted as is the dysregulation of chemokines and secretory IgA in IBD. Finally, the effect of the intestinal epithelial cell on T effector cell proliferation and differentiation are examined in the context of IBD with particular focus on T regulatory cells and the two-way interaction between the intestinal epithelial cell and certain immune cell populations.


📜 SIMILAR VOLUMES


Cell death in the colonic epithelium dur
✍ Lina Chen; Sun-Mi Park; Jerrold R. Turner; Marcus E. Peter 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

CD95 is a member of the death receptor family. It is a prototypical inducer of apoptosis that, upon binding of its cognate ligand (CD95L), forms a death-inducing signaling complex composed of adaptor molecules and initiator caspases that transmit the apoptosis signal. The CD95/CD95L system was impli

Lymphoma risk in inflammatory bowel dise
✍ Jennifer L. Jones; Edward V. Loftus Jr. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

With the increasingly widespread use of immunosuppressive and biologic agents for the treatment of Crohn's disease and ulcerative colitis come concerns about potential long-term consequences of such therapies. Disentangling the potential confounding effects of the underlying disease, its extent, sev

Chemokines and chemokine receptors in mu
✍ Noah P. Zimmerman; Rebecca A. Vongsa; Michael K. Wendt; Michael B. Dwinell 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

Chemokines, a large family of small chemoattractive cytokines, and their receptors play an integral role in the regulation of the immune response and homeostasis. The ability of chemokines to attract specific populations of immune cells sets them apart from other chemoattractants. Chemokines produce

Disability in inflammatory bowel disease
✍ Laurent Peyrin-Biroulet; Alarcos Cieza; William J. Sandborn; Nenad Kostanjsek; M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

The inflammatory bowel diseases (IBDs) are associated with a reduced quality of life. The impact of IBD on disability remains largely unknown. With the International Classification of Functioning, Disability, and Health (ICF) of the World Health Organization (WHO), we can now rely on a globally agre